| CAS Number |
Product Names |
Molecular Formula |
|
171869-94-6
|
MITOGEN ACTIVATED PROTEIN KINASE 2 FRAGMENT 326-339 |
C72H126N22O19 |
|
171869-95-7
|
Palmatine chloride hydrate SDS |
C21H24ClNO5 |
|
171874-45-6
|
6-HYDROXYMETHYL-2-MERCAPTOBENZOTHIAZOLE SDS |
C8H7NOS2 |
|
171874-46-7
|
7-HYDROXYMETHYL-2-MERCAPTOBENZOTHIAZOLE SDS |
C8H7NOS2 |
|
171874-47-8
|
2(3H)-Benzothiazolethione,4-(hydroxymethyl)-(9CI) SDS |
C8H7NOS2 |
|
171874-48-9
|
2(3H)-Benzothiazolethione,5-(hydroxymethyl)-(9CI) SDS |
C8H7NOS2 |
|
171874-50-3
|
4-Benzothiazoleethanol,2-amino-(9CI) |
C9H10N2OS |
|
171874-51-4
|
2(3H)-Benzothiazolethione,4-(2-hydroxyethyl)-(9CI) |
C9H9NOS2 |
|
171874-52-5
|
2(3H)-Benzothiazolethione,5-(2-hydroxyethyl)-(9CI) |
C9H9NOS2 |
|
171874-54-7
|
2(3H)-Benzothiazolethione,5-(3-hydroxypropyl)-(9CI) |
C10H11NOS2 |
|
171875-00-6
|
2-(4-CHLORO-3-NITRO-PHENYL)-1H-IMIDAZOLE |
C9H6ClN3O2 |
|
171876-22-5
|
Ethyl 6-chloro-5-nitro-3-pyridinecarboxylate SDS |
C8H7ClN2O4 |
|
171876-65-6
|
Piperazine ferulate SDS |
C14H20N2O4 |
|
171877-37-5
|
(R)-4-PHENYL-1,3-OXAZOLIDINE-2-THIONE |
C9H9NOS |
|
171877-39-7
|
(S)-4-BENZYL-1,3-THIAZOLIDINE-2-THIONE SDS |
C10H11NS2 |
|
171877-64-8
|
CYCLOPENT[HI]INDENO[4,3,2,1-CDEF]CHRYSENE |
C24H12 |
|
171877-74-0
|
1-Penten-3-one, 2-bromo- SDS |
C5H7BrO |
|
171877-91-1
|
3-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-3-DEOXY-L-MANNITOL |
C11H15N5O4 |
|
171877-93-3
|
4-(6-AMINO-9H-PURIN-9-YL)-2,5-ANHYDRO-4-DEOXY-DIMETHYL ACETAL L-MANNOSE |
C13H19N5O5 |
|
171879-75-7
|
2-[4-(Methylsulfanyl)phenyl]benzonitrile |
C14H11NS |
|
171879-99-5
|
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-6-methyl- SDS |
C8H7ClN2 |
|
171880-56-1
|
4-BROMO-5-NITRO-ISOQUINOLINE-1-CARBALDEHYDE SDS |
C10H5BrN2O3 |
|
171880-76-5
|
2-Quinoxalinecarbonitrile, 6,7-dimethyl-, 1,4-dioxide (9CI) |
C11H9N3O2 |
|
171881-36-0
|
5-BroMo-2-(diMethylaMino)benzaldehyde SDS |
C9H10BrNO |
|
171881-79-1
|
CBZ-DL-METHALLYLGLYCINE |
C14H17NO4 |
|
171882-12-5
|
3,4-BIS-(1,2-DIMETHYL-1 H-INDOL-3-YL)-1-PHENYL-PYRROLE-2,5-DIONE |
C30H25N3O2 |
|
171887-03-9
|
N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide SDS |
C5H4Cl2N4O |
|
171887-04-0
|
N-[2-Amino-4-chloro-6-[[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide |
C11H14ClN5O2 |
|
171888-75-8
|
Benzeneacetic acid, -alpha--hydroxy-4-(2-methylpropyl)-, (R)- (9CI) |
C12H16O3 |
|
171895-49-1
|
Methyl 4-(ethylcarbaMoyl)benzoate |
C11H13NO3 |
|
171895-59-3
|
2H-Pyran-2-one, 6-ethynyltetrahydro-4-hydroxy-, (4R-cis)- (9CI) |
C7H8O3 |
|
171896-30-3
|
6-acetamidoindole SDS |
C10H10N2O |
|
171897-74-8
|
Deacetyl Iodixanol |
C33H42I6N6O14 |
|
171904-24-8
|
BARLICAN |
|
|
171905-37-6
|
FMOC-D-PRO-CL |
C20H18ClNO3 |
|
171905-91-2
|
Methyl 3-(2-carboxyphenyl)benzoate SDS |
C15H12O4 |
|
171906-65-3
|
Carbamic acid, 3-azabicyclo[3.2.0]hept-1-yl-, 1,1-dimethylethyl ester (9CI) SDS |
C11H20N2O2 |
|
171915-93-8
|
2,9-Di(1,3-thiazol-2-tl)anthra2,1,9-def:6,5,10-d'e'f'diisoquinoline-1,3,8,10-tetrone |
C30H12N4O4S2 |
|
171916-75-9
|
(3AS)-5-AZIDO-7-BROMO-3A 4 5 7A-TETRAHY& SDS |
C9H12BrN3O3 |
|
171917-81-0
|
2-Thiophenemethanol, 2,5-dihydro-alpha-methyl-, 1,1-dioxide (9CI) |
C6H10O3S |
|
171918-46-0
|
Acetonitrile, (1-methyl-2-pyrrolidinylidene)-, (Z)- (9CI) |
C7H10N2 |
|
171918-47-1
|
Acetonitrile, (1-methyl-2-pyrrolidinylidene)-, (E)- (9CI) |
C7H10N2 |
|
171918-48-2
|
Acetonitrile, (1-methyl-2-piperidinylidene)-, (Z)- (9CI) |
C8H12N2 |
|
171918-49-3
|
Acetonitrile, (1-methyl-2-piperidinylidene)-, (E)- (9CI) |
C8H12N2 |
|
171919-36-1
|
1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 1-methyl- (9CI) SDS |
C9H8N2O |
|
171919-37-2
|
1-Methyl-7-azaindole-3-carboxylic acid SDS |
C9H8N2O2 |
|
171922-46-6
|
4-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID SDS |
C10H14BNO3 |
|
171924-94-0
|
Cyclopentanecarboxylic acid, 1-acetyl-, methyl ester (9CI) SDS |
C9H14O3 |
|
171924-95-1
|
Cyclopentanecarboxylic acid, 1-acetyl- (9CI) SDS |
C8H12O3 |
|
171925-18-1
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,7-tribenzoate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- SDS |
C29H27NO7 |
|
171925-19-2
|
8-Indolizinol, octahydro-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- SDS |
C29H33NO4 |
|
171925-20-5
|
1,2,7,8-Indolizinetetrol, octahydro-, 1,2,7-tribenzoate, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- SDS |
C29H27NO7 |
|
171925-21-6
|
1,2,7,8-Indolizinetetrol, octahydro-, tetraacetate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
C16H23 N O8 |
|
171925-22-7
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,7-tribenzoate 8-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C30H29NO9S |
|
171925-23-8
|
1,6,7,8-Indolizinetetrol, octahydro-, 1,6,8-tribenzoate 7-methanesulfonate, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
|
|
171925-24-9
|
1,6,7-Indolizinetriol, 8-azidooctahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C29H26 N4 O6 |
|
171925-25-0
|
1,2,7-Indolizinetriol, 8-azidooctahydro-, tribenzoate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
C29H26 N4 O6 |
|
171925-26-1
|
1,6,7-Indolizinetriol, 8-aminooctahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C29H28N2O6 |
|
171925-27-2
|
1,2,7-Indolizinetriol, 8-aminooctahydro-, tribenzoate (ester), 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- SDS |
C29H28N2O6 |
|
171925-28-3
|
1,6,7-Indolizinetriol, 8-aminooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
|
|
171925-29-4
|
Acetamide, N-(octahydro-1,6,7-trihydroxy-8-indolizinyl)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C10H18 N2 O4 |
|
171925-30-7
|
Acetamide, N-(octahydro-1,2,7-trihydroxy-8-indolizinyl)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
C10H18 N2 O4 |
|
171925-31-8
|
1H-Imidazole-1-carbothioic acid, O-1,6,7-tris(benzoyloxy)octahydro-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- SDS |
C33H29N3O7S |
|
171925-32-9
|
1,6,7-Indolizinetriol, octahydro-, tribenzoate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8a.beta.)- |
C29H27NO6 |
|
171925-33-0
|
1,6,7-Indolizinetriol, octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8a.beta.)- |
|
|
171925-34-1
|
1,2,7-Indolizinetriol, 8-fluorooctahydro-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
|
|
171925-35-2
|
8-Indolizinecarbonitrile, octahydro-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
|
|
171925-36-3
|
8-Indolizinecarbonitrile, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- SDS |
C30H32N2O3 |
|
171925-37-4
|
8-Indolizinemethanol, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- SDS |
C30H35NO4 |
|
171925-38-5
|
8-Indolizinemethanamine, octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C30H36 N2 O3 |
|
171925-39-6
|
Indolizine, 8-(fluoromethyl)octahydro-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C30H34 F N O3 |
|
171925-40-9
|
Propanoic acid, 2,2-dimethyl-, octahydro-1,6,7-tris(phenylmethoxy)-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C34H41NO5 |
|
171925-41-0
|
Propanoic acid, 2,2-dimethyl-, octahydro-1,6,7-trihydroxy-8-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
|
|
171925-42-1
|
Indolizine, octahydro-8-methoxy-1,6,7-tris(phenylmethoxy)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C30H35NO4 |
|
171925-43-2
|
Indolizine, octahydro-8-methoxy-1,2,7-tris(phenylmethoxy)-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
|
|
171925-44-3
|
1,6,7-Indolizinetriol, octahydro-8-methoxy-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |
C9H17NO4 |
|
171925-45-4
|
1,2,7-Indolizinetriol, octahydro-8-methoxy-, 1S-(1.alpha.,2.beta.,7.alpha.,8.alpha.,8a.alpha.)- |
|
|
171926-86-6
|
HCV NUCLEOPROTEIN (88-96) |
C46H60N12O13 |
|
171926-87-7
|
2-Debenzoyl-2-tigloyl 10-DAB SDS |
C27H38O10 |
|
171927-40-5
|
Ras/Rac Transformation Blocker, SCH 51344 SDS |
C16H20N4O3 |
|
171964-73-1
|
N-(4-METHOXYBENZOYL)-L-VALYL]-N-[(1S)-3,3,3-TR IFLUOR-1-ISOPROPYL2-OXOPROPYL]-L-PROLINAMIDE |
C24H32F3N3O5 |
|
171965-33-6
|
1,2,4-Methenopentalene-5-carboxaldehyde, octahydro-, (1alpha,2alpha,3abeta,4alpha,5beta,6aalpha,7R*)- (9CI) |
C10H12O |
|
171965-34-7
|
1,2,4-Methenopentalene-5-carboxaldehyde, octahydro-, (1alpha,2alpha,3abeta,4alpha,5alpha,6aalpha,7R*)- (9CI) |
C10H12O |
|
171967-71-8
|
5-(1-methyl-1H-indole-3-carbonyl)-1H-benzo[d]imidazol-2(3H)-one SDS |
C17H13N3O2 |
|
171967-74-1
|
3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one SDS |
C17H19N3O4 |
|
171967-75-2
|
(+-)-Ramosetron hydrochloride |
C17H17 N3 O . Cl H |
|
171973-67-4
|
(S)-O-[2-(Acetylamino)-3-O-benzoyl-2-deoxy-4,6-O-benzylidene-α-D-galactopyranosyl]-N-9-Fmoc-L-serine Phenacyl Ester |
C48H44N2O12 |
|
171973-69-6
|
2-(Acetylamino)-2-deoxy-3-O-acetyl-4,6-O-benzylidene-α-D-galactopyranose Trichloroacetimidate |
C19H21Cl3N2O7 |
|
171974-61-1
|
1H-Imidazole,2,5-dihydro-2-methyl-2,4-bis(1-methylethyl)-(9CI) |
C10H20N2 |
|
171974-62-2
|
1H-Imidazole,2,5-dihydro-2,4,5,5-tetramethyl-2-(1-methylethyl)-(9CI) |
C10H20N2 |
|
171974-75-7
|
2H-Imidazole,2-methyl-2,4-bis(1-methylethyl)-(9CI) |
C10H18N2 |
|
171977-44-9
|
2,4?DIBROMODIPHENYL ETHER |
C12H8Br2O |
|
171979-04-7
|
4-hydroxy-1-phenyl-octan-1-one SDS |
C14H20O2 |
|
171979-66-1
|
CALCIUM IONOPHORE VI SDS |
C104H116O8P4 |
|
171980-56-6
|
ANILOFOS OXON |
C13H19ClNO4PS |
|
172015-79-1
|
(1S–4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride SDS |
C11H12ClN5O*ClH |
|
172016-06-7
|
rac N,N-diethyl-2-(hydroxyMethyl)-1-phenyl-cyclopropanecarboxaMide SDS |
C15H21NO2 |
|
172016-29-4
|
Tricyclo[4.2.2.01,6]deca-2,4,9-trien-7-amine (9CI) SDS |
C10H11N |
|
172016-60-3
|
(1R,2S,3R,5S,δZ)-2-(tert-Butyldiphenylsilyloxy)methyl-5-hydroxy-3-tetrahydropyranyloxy-cyclopentanehept-δ-en-oic Acid Methyl Ester (Mixture of Diastereomers) |
C35H50O6Si |
|
172018-16-5
|
13- |
C29H36O10 |